Our work is done in collaboration with, or under the expert advice of renowned clinicians and key opinion leaders, and some of the most important worldwide Pharma players (Eli-Lilly, Merck, Alnylam, GKS, Pharmamar, NovoNordisk) so as to be up to date with the unmet medical needs and benchmarks, as well as with the drug and industry trends in our field.
Our translational vision is underlined by the filing for 23 patent families, the licensing-out of most of these inventions to pharma biotech companies, and the establishment of strong alliances.
Currently we are collaborating with:
– ELI LILLY (2024-2027)
– ALNYLAM (2023-2027)
– QUANTUM BIOSCIENCES (2023-2027)
– CERTEST (2023-24)
– PHARMAMAR (2023-25)
– PHARMAMIX (2023-24)
Finally, the lab has promoted the creation of two start-up companies:
LIBERA-BIO (2021 to present) https://www.liberabio.com
SMART VITAMINS (2021 to present) http://smartvitamins.org
